Pharmabiz13h
Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay
Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...
Pharmabiz8h
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
Pharmabiz15h
Sai Life Sciences in Q3 reports revenue of Rs. 439.8 crore with 14.6% growth; Net profit up 36% year-on-year
Sai Life Sciences in Q3 reports revenue of Rs. 439.8 crore with 14.6% growth; Net profit up 36% year-on-year: Our Bureau, Bengaluru Friday, February 7, 2025, 11:50 Hrs [IST] Sai L ...
Pharmabiz11h
CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL
CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL: San Diego Friday, February 7, 2025, 15:00 Hr ...
Pharmabiz10h
Actimed Therapeutics’ anti-catabolic and pro-anabolic transforming agent, S-pindolol benzoate receives US & European patents
Actimed Therapeutics’ anti-catabolic and pro-anabolic transforming agent, S-pindolol benzoate receives US & European patents: London, UK Friday, February 7, 2025, 16:00 Hrs [IST ...
Pharmabiz15h
Waters ElectroForce Apex 1 instrument offers increased speed to test advanced polymer materials
Waters ElectroForce Apex 1 instrument offers increased speed to test advanced polymer materials: Our Bureau, Bengaluru Friday ...
Pharmabiz14h
Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego
Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego: Paris Friday, February 7, 2025, 12 ...
Pharmabiz16h
Equillium and Biocon announce positive data from phase 2 study of itolizumab to treat moderate to severe ulcerative colitis
Equillium and Biocon announce positive data from phase 2 study of itolizumab to treat moderate to severe ulcerative colitis: Our Bureau, Bengaluru Friday, February 7, 2025, 10:30 ...
Pharmabiz18h
Panel recommends Centre to strengthen regulatory framework for ADR on Ayush medicines
A Parliamentary Panel has sought the Ministry of Ayush to furnish details of action taken by the authorities to strengthen regulatory framework for adverse effects reporting and conduct regular post ...
Pharmabiz9h
Essential Pharma & Clinigen expand collaboration to improve patient access in JAPAC
Essential Pharma & Clinigen expand collaboration to improve patient access in JAPAC: Egham, UK Friday, February 7, 2025, 17:00 Hrs [IST] Essential Pharma, an international special ...
Pharmabiz15h
Ariceum Therapeutics’ proprietary radiopharmaceutical cancer therapy, 225Ac-SSO110 receives US FDA orphan drug designation
Ariceum Therapeutics’ proprietary radiopharmaceutical cancer therapy, 225Ac-SSO110 receives US FDA orphan drug designation: Berlin, Germany Friday, February 7, 2025, 11:00 Hrs [ ...
Pharmabiz15h
Indian pharma expected to grow at 9-10% in FY26, says Ind-Ra Ratings
Indian pharma expected to grow at 9-10% in FY26, says Ind-Ra Ratings: Our Bureau, New Delhi Friday, February 7, 2025, 11:45 Hrs [IST] Credit rating firm India Ratings and Research ...